Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

LIPO-C Legal 2026 Status: [Research vs Clinical Use] Comparison

Legal Basis 21 CFR 312.2(b)(1) investigational use exemption Section 503A/503B patient-specific compounding None. Requires FDA drug approval Research peptides are federally protected; clinical requires prescription; bulk products face enforcement Prescription

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Legal Basis
  • 21 CFR 312.2(b)(1) investigational use exemption
  • Section 503A/503B patient-specific compounding
  • None. Requires FDA drug approval
  • Research peptides are federally protected; clinical requires prescription; bulk products face enforcement
  • Prescription Required
  • No. Sold to institutions
  • Yes. Individualised Rx per patient
  • Claimed 'no' but legally required
  • Only clinical pathway allows individual consumer access, and only with valid Rx
  • Buyer Verification
  • Institutional affiliation required
  • Prescriber-patient relationship verified
  • Often none or minimal
  • Legitimate suppliers verify research credentials or prescriber licensure
  • Permitted Marketing Claims
  • None. 'for research use only'
  • None. Compounded under prescription
  • Often make therapeutic claims illegally
  • Therapeutic claims without approval = federal violation
  • Supplier Registration
  • FDA-registered peptide manufacturer
  • State-licensed pharmacy (503A) or FDA-registered outsourcing facility (503B)
  • Often unregistered or foreign
  • Registration status determines enforcement risk
  • Primary Enforcement Risk
  • Minimal if compliance maintained
  • State pharmacy board oversight
  • High. FDA Warning Letters common
  • Research and compliant clinical pathways are low-risk; grey-market bulk sales face active enforcement
  • The key differentiator: intended use. A peptide sold with a certificate of analysis to a university biochemistry lab is research. The same peptide sold to an individual consumer with dosing instructions on the website is an unapproved drug.